Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Fetal Liver Metabolism of Oxycodone Is Mediated by CYP3A7. | AAPS J | 2021 | 33438174 | PubTator, text mining | PubMed |
| Involvement of Organic Anion Transporters in the Pharmacokinetics and Drug Interaction of Rosmarinic Acid. | Pharmaceutics | 2021 | 33435470 | PubTator, text mining | PubMed |
| Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Healthy Japanese and Western Subjects. | Clin Pharmacol Drug Dev | 2021 | 33434408 | PubTator, text mining | PubMed |
| Spontaneous intermuscular hematoma in a patient receiving ticagrelor and aspirin: A case report. | Biomed Rep | 2021 | 33408862 | PubTator, text mining | PubMed |
| UGT1A6 and UGT2B7 Gene Polymorphism and its Effect in Pediatric Epileptic Patients on Sodium Valproate Monotherapy. | Indian J Pediatr | 2021 | 33400134 | PubTator, text mining | PubMed |
| Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer. | Theranostics | 2021 | 33391469 | PubTator, text mining | PubMed |
| Whole-exome Sequencing of Prostate Cancer in Sardinian Identify Recurrent UDP-glucuronosyltransferase Amplifications. | J Cancer | 2021 | 33391440 | PubTator, text mining | PubMed |
| The N6-methyladenosine modification posttranscriptionally regulates hepatic UGT2B7 expression. | Biochem Pharmacol | 2021 | 33387482 | PubTator, text mining | PubMed |
| Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism. | Expert Opin Drug Metab Toxicol | 2021 | 33322962 | PubTator, text mining | PubMed |
| Physiologically-Based Pharmacokinetic Modeling of the Drug-Drug Interaction of the UGT Substrate Ertugliflozin Following Co-Administration with the UGT Inhibitor Mefenamic Acid. | CPT Pharmacometrics Syst Pharmacol | 2021 | 33314761 | PubTator, text mining | PubMed |
| Drug glucuronidation assays on human liver microsomes immobilized on microfluidic flow-through reactors. | Eur J Pharm Sci | 2021 | 33309889 | PubTator, text mining | PubMed |
| Inhibition of human UDP-glucuronosyltransferase enzyme by belinostat: Implications for drug-drug interactions. | Toxicol Lett | 2021 | 33290829 | PubTator, text mining | PubMed |
| Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units. | Expert Opin Drug Metab Toxicol | 2021 | 33256492 | PubTator, text mining | PubMed |
| Drug-drug interaction of atazanavir on UGT1A1-mediated glucuronidation of molidustat in human. | Basic Clin Pharmacol Toxicol | 2021 | 33232579 | PubTator, text mining | PubMed |
| Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. | Br J Clin Pharmacol | 2021 | 33217013 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| What dominates the changeable pharmacokinetics of natural sesquiterpene lactones and diterpene lactones: a review focusing on absorption and metabolism. | Drug Metab Rev | 2021 | 33211987 | PubTator, text mining | PubMed |
| A transcriptome profile in gallbladder cancer based on annotation analysis of microarray studies. | Mol Med Rep | 2021 | 33179115 | PubTator, text mining | PubMed |
| Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers. | Anesth Analg | 2021 | 33177323 | PubTator, text mining | PubMed |
| Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients. | Br J Pharmacol | 2021 | 33155675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=35